ArticleFrontiers in cardiovascular medicine2026
Pre-procedural left atrial strain and clinical features for predicting recurrence after first catheter ablation of persistent atrial fibrillation: a prospective cohort study.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Recurrence after the first ablation for persistent atrial fibrillation (AF) is common. Existing clinical and structural prediction models have limited performance. Peak atrial longitudinal strain (PALS) quantifies left atrial function and may improve risk stratification. Objective: To develop and validate a 12-month recurrence prediction model for persistent AF by integrating PALS with clinical features, and to evaluate its performance and clinical utility. Methods: Single-center prospective cohort; of 629 patients screened, 429 were enrolled, and 410 were included in the final analysis after exclusions for image quality and loss during the blanking period. Pre-procedural PALS was measured with standardized quality control. The outcome was the first recurrence (>30 s) between the end of the 90-day blanking period and 12 months. Cox models with restricted cubic splines assessed the dose-response. Model performance (C-index, time-dependent AUC, Brier score, calibration) was compared among "Clinical-only", "Clinical + PALS", and "Clinical + LAVI" models. Reclassification (NRI/IDI) and clinical net benefit (decision curve analysis) were evaluated, along with sensitivity and interaction analyses. Results: PALS independently predicted recurrence (per 1% decrease: HR 1.06, 95% CI 1.03-1.10; Conclusions: Pre-procedural PALS significantly improves individualized prediction of 12-month recurrence after first ablation for persistent AF when combined with clinical features. The model shows robust performance and clinical net benefit, supporting PALS as a core functional metric in pre-procedural assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.